In a historic milestone for neurotechnology, Coherence Neuro—a San Francisco-based longevity startup with close ties to Elon Musk’s Neuralink—has commenced human testing of a specialized brain implant designed to detect and disrupt cancer.
After surging nearly 50% since its record-breaking IPO, SpaceX shares declined for the first time as investors booked profits, broader market weakness weighed on sentiment, and traders assessed the company's path toward major index inclusion.
